<DOC>
	<DOCNO>NCT00898820</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood laboratory patient receive pemetrexed disodium may help doctor learn effect pemetrexed disodium cell . It may also help doctor understand well patient respond treatment . PURPOSE : This laboratory study look blood sample patient stage III stage IV non-small cell lung cancer enrol clinical trial MCCRC-RC0524 determine effect pemetrexed disodium cell .</brief_summary>
	<brief_title>Tumor Response Pemetrexed Disodium Patients With Stage III Stage IV Non-Small Cell Lung Cancer Enrolled Clinical Trial MCCRC-RC0524</brief_title>
	<detailed_description>OBJECTIVES : Primary - Assess intracellular level pemetrexed disodium ( PD ) polyglutamates measure activity PD transport activation enzymes patient stage III IV non-small cell lung cancer enrol clinical trial MCCRC-RC0524 . Secondary - Assess polymorphisms gene expression PD target gene gene encode enzyme involve transport , activation , inactivation PD patient . - Correlate haplotype-tagged single-nucleotide polymorphism ( htSNPs ) gene expression level intracellular level PD polyglutamates - Correlate htSNPs gene expression level toxicity efficacy PD . OUTLINE : Blood drawn prior 24 hour day 1 course 1 pemetrexed disodium . DNA extract genotyped know polymorphisms gene involve transport , activation , inactivation , mechanism action resistance pemetrexed disodium , include reduced folate carrier-1 , multiresistance protein ( particularly MRP5 ) , folate receptor , folypolyglutamate synthase , methylenetetrahydrofolate reductase ( MTHFR ) , methionine synthase , methylthioadenosine phosphorylase , thymidylate synthase ( TS ) , dihydrofolate reductase , glycinamide ribonucleotide formyltransferase . Plasma red blood cell also process intracellular polyglutamate assay pemetrexed disodium high-performance liquid chromatography-based method . PROJECTED ACCRUAL : A total 80 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Enrolled clinical trial MCCRCRC0524 Willing provide blood sample PATIENT CHARACTERISTICS : No investigator site personnel directly affiliate study , immediate family investigator site personnel directly affiliate study Immediate family define spouse , parent , child , sibling , whether biological legally adopt Not employ Eli Lilly ( i.e. , employee , temporary contract worker , designee responsible conducting study ) Immediate family Eli Lilly employee allow , may participate Eli Lilly facility PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
</DOC>